Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
Our understanding of the genetics and treatment options for primary effusion lymphoma (PEL) is lacking. Here the authors performed in vitro CRISPR/Cas9 knock-out screens to identify 210 PEL-specific oncogenic genes and report strategies for therapeutic intervention.
Enregistré dans:
Auteurs principaux: | Mark Manzano, Ajinkya Patil, Alexander Waldrop, Sandeep S. Dave, Amir Behdad, Eva Gottwein |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4753b6af0a0c4636a623f9ba180cea46 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
par: Mark Manzano, et autres
Publié: (2020) -
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
par: Chong Wang, et autres
Publié: (2020) -
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
par: Hamidreza Aboulkheyr Es, et autres
Publié: (2021) -
Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma
par: Carolina Caro-Vegas, et autres
Publié: (2019) -
Evolutionarily conserved herpesviral protein interaction networks.
par: Even Fossum, et autres
Publié: (2009)